Clinical Trial Update: A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin [Phase 1]

View source ↗

Summary

Phase 1 trial completed to evaluate the effect of AB-106 on the pharmacokinetics of digoxin in patients with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• AB-106
• DIGOXIN (Digoxin)

Snippet

Sponsor: Nuvation Bio Inc. | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED